Effect of the COLIA1Sp1 polymorphism on bone density in sarcoidosis patients

E. Puscinska, A. Norek, D. Chmielewski, K. Szamotulska, A. Goljan-Geremek, A. Rudnicka, M. Bednarek, J. Grudny, A. Sobczynska-Tomaszewska, J. Bal, D. Górecka (Warsaw, Poland)

Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session: Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session type: E-Communication Session
Number: 3143
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Puscinska, A. Norek, D. Chmielewski, K. Szamotulska, A. Goljan-Geremek, A. Rudnicka, M. Bednarek, J. Grudny, A. Sobczynska-Tomaszewska, J. Bal, D. Górecka (Warsaw, Poland). Effect of the COLIA1Sp1 polymorphism on bone density in sarcoidosis patients. Eur Respir J 2009; 34: Suppl. 53, 3143

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of polymorphisms in the Col1a1, CTR and VDR genes on the risk of low bone density and osteoporotic fractures in patients with severe asthma receiving oral glucocorticoids
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006

Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Bone mineral density in patients with COPD depending on pulmonary function parameters
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Clinical impact of the relationship between low bone mineral density and peripheral muscle strength in patients with COPD
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012

Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor
Source: Eur Respir J 2005; 25: 54-61
Year: 2005



Bone mineral density and calciun metabolism in sarcoidosis at clinical onset
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004

Loss of bone mineral density in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007


The relationship between leptin and proinflammatory cytokines with bone mineral density in patients with sarcoidosis (pts)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008

Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity?
Source: Eur Respir J 2005; 26: Suppl. 49, 526s
Year: 2005

The influence of TNFα gene polymorphism on the therapeutic response in patients with sarcoidosis
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012

Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Mineral density of bone tissue in sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 232s
Year: 2003

Association of VDR, COL1A1 and CALCR genes polymorphisms with susceptibility to steroid osteoporosis in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010


Low-dose chest CT for bone mineral density in pediatric patients with cystic fibrosis
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020

DeltaF508 genotype for cystic fibrosis is significantly associated with reduced bone mineral density (BMD) in adults with CF
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002

Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation
Source: Eur Respir J 2006; 28: Suppl. 50, 71s
Year: 2006

A comparison of bone mineral density in elderly patients with COPD and bronchial asthma
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


IL-1α gene polymorphism in pulmonary sarcoidosis in relation to disease severity
Source: Eur Respir J 2002; 20: Suppl. 38, 172s
Year: 2002